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Nelson Chijioke Nwaiwu, M.S.
Texas Southern University, 2021
Professor Zivar Yousefipour, Ph.D., Advisor
Research has shown that acrolein, a known environmental pollutant, contributes to
generation of free radicals leading to oxidative stress and physiological damage. Curcumin
has been known to improve damages from oxidative stress due to its antioxidative and antiinflammatory properties. It has been reported that to exert such an effect, a large dose of
curcumin needs to be consumed on daily bases due to its high excretion through kidney.
Here in collaboration with Dr. Chelliah from department of pharmaceutical, an analog form
of curcumin (compound-20) was synthesized with promising more potent activity and
absorption. The objective of this study was to investigate if compound-20 could prevent
acrolein induced oxidative stress in rats.
Acrolein is a reactive aldehyde, which is released as a byproduct of organic
combustion such as in cigarette smoke, burning of wood, automobile exhaust, diesel fuel,
paraffin wax, and heating cooking oil at high temperatures. (Tanel et al., 2014; Stevens et
al., 2008). Acrolein has its uses which include production of pesticides, algaecide, and
aquatic herbicide in irrigation canals (Arntz et al., 2013). High level of acrolein has been
1
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reported in different disease conditions such as spinal cord injury, multiple sclerosis,
diabetes mellitus, neurological, nephrological and hepatological toxicity, Alzheimer’s, and
cardiovascular disease (Akshata et al., 2015).
Curcumin is a natural product, widely used in cooking preparations thorough out
the world. As a polyphenol compound, curcumin (CUR) is isolated from the rhizome of
Curcuma longa and chemically defined as diferuloylmethane. CUR has powerful
antioxidant and anti-inflammatory activities (Kunnumakkara et al., 2017). However, when
consumed as a spice in preparation of food, large amount of the compound will be excreted
due to its poor absorption from small intestine as well high metabolism by liver (Dei Cas
and Ghidoni, 2019). To overcome these limitations, different approaches including
synthesizing novel solid or liquid forms have investigated
Here at Texas Southern University, our collaborator, Dr. Chelliah and his group
have been successful in synthesizing several solid analogs of curcumin with more potent
and absorption property (Chelliah et al., 2019). In this study, we hypothesized that one of
the curcumins analog, which is referred as compound-20 here on, is effective on
prevention/reversal of toxic damage caused by acrolein by improving antioxidant system,
removing free radicals and ultimately, reducing the inflammation.
Effects of compound-20 in amelioration of changes caused by acrolein was
examined in rat’s serum. Lipid peroxidation, total glutathione, superoxide dismutase, and
glutathione-s-transferase activities were measured using ELISA kits from ABCAM
including Lipid peroxidation assay kit (Colorimetric), GSH + GSSG/GSH assay kit
(Colorimetric), Superoxide dismutase activity (colorimetric), and GST activity assay kit
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(colorimetric) respectively.Male Sprague Dawley rats weighing 250-350kg were
purchased from Envigo (Indianapolis 190 United States) and were divided into three
groups: Control group (same amount of vehicle), acrolein group (2mg/kg/day, i.p 7days),
and Group 3 includes rats treated with compound-20 (10mg/kg/day, 3days, gavage) before
acrolein treatment of (2mg/kg/day, 4days i.p). At the end of the treatment, rats were
sacrificed, and tissues and blood were harvested for further analysis. Blood was collected
in heparin containing syringes (cardiopuncture, 8-10 ml) in anesthetized rats. Collected
blood was centrifuged at 1000 X g for 10 minutes and the supernatant was collected. We
used the serum to carry out different assays following manufacturer protocols. The results
were analyzed using Unpaired t-test and one-way ANOVA and the data with P values
P≤0.05 were reported as significant change. Our result showed a decreased level of GST
activity, Glutathione, and SOD activity, but increased lipid peroxidation, in the group
treated with acrolein. Addition of compound-20 (C20) increased glutathione, GST, AND
SOD activities, while lipid peroxidation was decreased.
In conclusion, based on our results, we are reporting that changes in rats after
exposure to acrolein are ameliorated after addition of C20. Furthermore, we are including
that daily dose of C20 might be a preventive approach to reduce effects of compounds like
acrolein in population that are living in areas with high level of acrolein in the environment.
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CHAPTER 1
INTRODUCTION
Acrolein
Acrolein is a reactive α, β-unsaturated aldehyde, which is abundant in organic
combustion such as cigarette smoke, burning of wood, automobile exhaust, diesel fuel,
paraffin wax, heating cooking oil to high temperatures. (Tanel et al., 2014; Stevens et al.,
2008). Acrolein is a colorless liquid with a piercing smell, an environmental pollutant, and
it is used in the production of methionine, and in methyl chloride refrigerant.
Acrolein can be also generated as a product of endogenous threonine metabolism
(mediated by myeloperoxidase) and/or spermine metabolism (mediated by amide oxidase)
(Faroon et al., 2008; Stevens et al., 2008). During inhalation of environmental tobacco
smoke or cigarette smoke, the concentrations of acrolein at the airway surface can be as
high as 80μM (Eiserich et al., 2010 and Li et al., 2008). Although acrolein exposure through
inhalation has been extensively investigated, systemic exposure to acrolein is still of
interest to many investigators.
Physical Properties of Acrolein
Acrolein is a clear or yellow liquid with a burned, sweet, pungent odor that most
people may begin to smell at air concentrations around 0.25 ppm (0.6 milligrams per cubic
meter) (ATSDR, 2007). The chemical formula for acrolein is C-3-H-4-O and the
1
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molecular weight is 56.06 g/mol (ATSDR, 2007). The vapor pressure for acrolein is 274
mm Hg at 25°C, and its log octanol/water partition coefficient (log K ow) is -0.01.

Figure 1:

The Physical State and Structure of Acrolein from (ATSDR, 2007)

Acrolein is a pervasive toxic compound readily released into the environment from
diverse sources. Due to its high availability in the environment, it poses a health threat to
both human and animals. Environmental Protection Agency (EPA) has listed acrolein as a
priority toxic compound to the environment (EPA, 2007).
The acute minimal level of acrolein approved by Agency for Toxic Substance and
Disease Registry (ATSDR) is 0.003 ppm (0.007 mg/cm3) based on respiratory effects on
human (ATSDR, 2003). Currently, the estimate for Tolerable Daily Intake (TDI) for
acrolein is 7.5 mg/kg body weight as recommended by World Health Organization
(Abraham et al., 2011).
Sources and Exposure of Acrolein
The sources of acrolein that are most relevant to human exposure and toxicity can
be grouped into dietary, endogenous, and environmental sources. Environmental sources
include burning of wood, plastic, combustion of fossil fuels, cigarette smoke, and
overheating of frying oil. Also, acrolein is industrially produced by oxidation of propene,
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a thermal formation of acrolein through hydroxyl dehydration of glucose (Jan & Claudia,
2008). However, endogenous source of acrolein is produced by lipid peroxidation,
metabolism of anticancer drug- cyclophosphamide and polyamine metabolism (Maier et
al., 2001; Steven et al., 2008). Nonetheless, dietary sources include consumption of charred
meat, roasted coffee, alcoholic beverages, and fried foods. (Jan & Claudia, 2008). Also,
carbohydrates can be a source of acrolein, during their metabolism process. Heating or
baking of carbohydrate-containing foods at high temperature can result in the formation of
reactive carbohydrate intermediates that can undergo carbon-carbon cleavage or react with
amino acid residues in proteins. For example, heating of glucose may result in loss of the
hydroxyl group at position 4 through dehydration, which would yield the appropriate βhydroxy ketone moiety for release of the acrolein precursor, hydroxy acetone, via retro
aldol cleavage of the 3,4-bond (Yaylayan et al., 2007). This information has initiated the
investigation of systemic exposure of acrolein.

4

Figure 2: Carbohydrate a Source of Acrolein. (Source: Pub Med., 2008 Jan)
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Figure 3:

The Sources and Metabolic Fate of Acrolein in Atherosclerotic Plaque
Formation (Sanjay et al., 2011)
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Nonetheless, in the manufacturing process of cigarettes, glycerol is added to
tobacco in the range of about 1-5% by weight to maintain moisture and to absorb added
flavors. In a toxicological evaluation study of glycerol as a cigarette ingredient, it was
found that addition of glycerol at rates of 10g or 15g per 100g tobacco led to a significant
9% increase of acrolein in the smoke (67 and 69μg/cigarette, respectively), compared to
the glycerol addition rate of 5g per 100 g tobacco (60μg acrolein/cigarette) and the control
cigarettes (56μg acrolein/cigarette) (Carmines et al., 2005). An obvious source of acrolein
is the glycerol component of triacyl and diacyl glycerides, but acrolein can also be formed
from fatty acids during the mechanism of formation of 4-hydroxynonenal from linoleic
acid (Schneider et al., 2001 and Schneider et al., 2005).

Figure 4:

Source of Acrolein from Glycerol (Arachidonic Acid)
(Yin et al., 2005)
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Also, working in or living near industries where acrolein is manufactured or used
to make other chemicals can stand as a big threat of exposure. Inhaling vapors from
overheated cooking oil or grease and consuming foods cooked at high temperature can also
lead to exposure to acrolein (ATSDR, 2007).
In addition, heating, or combustion of Polyunsaturated fatty acids (PUFAs)
produces acrolein. Then biodiesel is a source of exposure to acrolein. Indeed, acrolein
emissions from biodiesel combustion are related to fuel quality and glycerol content.
(Graboski et al., 2001).
Metabolism of Acrolein
Acrolein is soluble in water, in alcohol, and in diethyl ether, and therefore it can
travel across membranes by passive diffusion. The main pathway for elimination of
acrolein is conjugation with glutathione (GSH) in the liver, followed by enzymatic
cleavage of the γ-glutamic acid and glycine residues, respectively, in the liver and in the
kidney (Josch et al., 2003)
Due to high acrolein solubility, absorption into the body system is made easy, which
enables it to bind and form conjugates of endogenous glutathione (GSH), N- acetylcysteine
(NAC) as well as thioredoxin. This binding can proceed both in presence or absence of a
catalyst and the common catalyst is glutathione-S-transferases. The conjugate acroleinGSH may be metabolized by enzymatic cleavage of γ-glutamic acid and glycine residues.
Also, acrolein can be metabolized through aldehyde dehydrogenase which results in 2carboxyethyl mercapturic acid (CEMA). The reaction can be catalyzed by Aldo-keto
reductase resulting in S-(3- hydroxypropyl)-N-acetylcysteine (3-HPMA), which is the
major urinary by-product of acrolein (Shirish et al., 2015). The byproducts of acrolein can
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undergo epoxidation and oxidation reaction with glutathione conjugates to form
glyceraldehyde which may pose health effects in humans due to its carcinogenetic
characteristics when applied dermally in mice and rats (Bryan et al., 2015).
Therefore, acrolein irreversible adduct formation with cellular nucleophiles could
be the basis of different toxic effects of acrolein on human and animals (Stevens and Maier,
2015).
Uses of Acrolein
Acrolein has its uses which include production of pesticides, used as an algaecide,
and used as an aquatic herbicide in irrigation canals (Arntz et al., 2013). Also, it is used as
micro biocide in oil wells, it is used in the production of perfumes and plastics, and
production of colloidal forms of metals. Nonetheless, acrolein can be used as slimicide in
manufacturing paper, it is used as a warning agent in methyl chloride refrigerant, it is
sometimes used as a fixative in preparation of biological specimen in electron microscopy,
it is used in the manufacture of poisonous gas mixtures for military purposes, and in water
treatment ponds; it is used in production of liquid hydrocarbon fuels, and cooling-water
towers.
Health Effects of Acrolein
Inhalation of acrolein in the smoke from tobacco cigarettes has been connected to
the risk of lung cancer (Dietrich et al., 2012). Nonetheless, acrolein has been known to be
a health hazard commonly found at significant levels in most homes and schools in the
United States (Lambert et al., 2005). Also, EPA has indicated that humans are exposed to
acrolein through different medium such as airborne, occupational, and dietary exposure.
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Nonetheless, firefighters, industry workers, persons inhabiting densely polluted cities,
cigarette and hookah smokers are substantially exposed to acrolein (Kassem et al., 2014).
Acrolein has been reported to have adverse health effects on different organs of the body
including the eye leading to redness, irritation, and inflammation; the skin; causing skin
irritation, as well as lung and upper respiratory tract congestion (Kassem et al., 2014).
Studies have indicated that acrolein is involved in different disease conditions, for
example spinal cord injury, multiple sclerosis, diabetes mellitus, neurological,
nephrological and hepatological toxicity, Alzheimer’s, and cardiovascular disease
(Akshata et al., 2015). Also, deleterious effects such as oxidative stress, mitochondrial
disruption, membrane damage, endoplasmic reticulum stress, immune dysfunction,
protein, and DNA adduction can result from cellular molecules reacting with acrolein
(Craig et al., 2015).
Acrolein is reported to have adverse effect on human umbilical vein endothelial
cells (HUVEC) which are essential for the expansion of blood vessel wall, shear forces,
and the progression of atherosclerotic plaques (Zhang et al., 2010).
O’toole et al., 2014, conducted a study using HUVECs, treated with 10 uM of
acrolein and incubated for 6 hours. The outcome indicated that acrolein deregulated aortic
insulin sensitivity, reduced cell movement, and deregulate AKT phosphorylation.
In a 2005, a study was carried out by Dr. Yousefipour and her research team where
rat models were treated with 2 and 4 mg acrolein/kg body weights. The result showed
elevated blood pressure due to a reduction in nitric oxide availability, a rise in lipid
peroxidation, and a decrease in Cyclic guanosine monophosphate (cGMP). The authors
concluded that the increase in blood pressure was because of depletion of GST and GST-
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Px detoxifying enzymes that inflated vascular response to phenylephrine. (Yousefipour et
al., 2005).
Compound-20 (Analog of curcumin)
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a
polyphenolic compound isolated from the plant rhizome called Curcuma longa Linn.
(Anderson et al., 2000 and Selvam et al., 2005). Curcumin has diverse pharmacological
action towards several diseases which constructively dragged the attention and interest to
the medicinal chemistry researchers to develop new analogs to address the therapeutic
problem.

Figure 5:

Structure of Curcumin and its Analogs
(Philips et al., 2013; Philips et al., 2011)
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Compound-20
Outside curcumin, several investigators have synthesized different analogs of
curcumin. Dr. Selvam from the Department of Pharmaceutical Science and his team has
developed several analogs of curcumin, which compound-20 is an example of these
analogs. These analogs have shown antioxidative effects to cancer cells. This has made us
to investigate the effects of compound-20 in acrolein induced toxic effects.
Uses of Curcumin
Curcumin natural alternative is the Phyto drug named curcumin (CUR) which is
isolated from the rhizome of Curcuma longa and chemically defined as diferuloylmethane.
CUR has powerful antioxidant and anti-inflammatory activities, among others
(Kunnumakkara et al., 2017).
CUR serves to be the best chemoprotective and chemotherapeutic agent amongst
all. Furthermore, CUR has been suggested for the treatment of liver, breast, ovarian,
prostate, pancreatic and colorectal cancers so far. Inflection in the vital enzymes,
transduction and inflammatory pathways, induction of cell cycle arrest and apoptotic nature
have been emphasized for CUR anticancer activity and have been found to serve better.
Though on oral administration, it is chemically unstable, has poor aqueous solubility,
undergoes rapid metabolism, and tapered systemic distribution by conventional techniques
like synthetic CUR analogues, synergistic combination therapy and novel drug delivery
system are a required system to be implemented to overcome the pharmacokinetic
limitations of curcumin on oral administration (Chelliah et al., 2019). Furthermore, it has
been documented that CUR modulates signal transduction and gene expression. Benefit
effects of CUR are due to its interactions with growth factors, receptors, transcriptional
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factors, cytokines, enzymes, and genes that regulate apoptosis. It has been shown that CUR
acts as a scavenger against reactive oxygen and nitrogen species (RONS) and in vivo, CUR
enhances the activity of superoxide dismutase, catalase, and glutathione peroxidase (Gupta
et al., 2011). Such properties support its potential for preventive and therapeutic
applications. Curcumin analogues are known to be having turmerones modulate antiinflammatory signaling and cell proliferation signaling. The protective mechanism of CUR
associated with anti-inflammation, is thought to be related to the regulation of COX-2.
Inflammatory mediators such as COX-2 and cytokines play a crucial role in chronic
inflammation process. However, compound-20 is a synthetic form of CUR or can be called
an analog of CUR but with more potency than curcumin itself (Chelliah et al., 2019).

CHAPTER 2
LITERATURE REVIEW
Mechanism of Acrolein Toxicity
Acrolein is known to cause many adverse effects at both cellular and molecular
level in humans. The mechanisms by which it causes its toxicity could be directly as protein
adduction or indirectly as oxidative stress, endoplasmic reticulum, and mitochondrial
stress, and inflammation, relating to several disease conditions (Akshata et al., 2015). Also,
acrolein can be harmful to the system through the deterioration of the body’s defense
mechanism against viral and bacterial infection through the inhibition of macrophage
response by suppressing NF-kB (Horton et al., 1999; Kehrer et al., 2000; Kirkham et al.,
2004; Lambert et al., 2005). Toxicity can also occur by signaling protein alkylation as well
as repressing anti-inflammatory response and enhancing proinflammatory reaction which
are mostly seen in cigarette smokers (Hristova et al., 2012; Kasahara et al., 2008; Valacchi
et al., 2005).
Acrolein Adduction to Phosphatases
Electrophile-mediated stress does not only affect the transcription of many genes
but also interferes with redox-sensitive signal transduction pathways, because many
constituents of these pathways have reactive cysteine residues (Zhang et al., 2003). The
consequences of the reaction of acrolein with functionally critical protein thiol residues of
13
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protein tyrosine phosphatases (PTPs) have been recognized (Zhang et al., 2003). It is
reported that inactivation of PTPs through acrolein adduction to cysteine in the active site
leads to disruption of normal cellular signaling cascades and should be considered as an
important chemical mechanism contributing to the cellular toxicity of acrolein (Takeuchi
et al., 2001).
Acrolein Adduction to Amino Acids and Cross-linking of Proteins
Numerous studies indicate that acrolein-induced toxic effects can to some extent be
rationalized by depletion of cellular GSH (Kehrer et al., 2001). In addition, acrolein exerts
its biological effects through reaction with nucleophilic sites in proteins, i.e., the sulfhydryl
group of cysteine, the imidazole moiety of histidine, and the ε-amino group of lysine,
thereby impairing protein function (Kehrer et al., 2001).
Due to its electrophilic nature, acrolein can readily bind with cellular nucleophiles
such as DNA and RNA which results in toxic responses. It binds to the sulfhydryl group
of cysteine, the amino group of lysine, and the imidazole group of histidine resulting in
Michael addition adducts (Pizzimenti et al., 2013; Zarkovic et al., 2013). Acrolein binds to
and inhibits amino acid residues from carrying out their cellular protection and function
thereby exposing the body to free radicals (reactive oxygen species) which are the chief
cause of oxidative stress and cause of cell damage (Smita et al., 2015). Michael and Schiff’s
base formation are the two mechanisms by which acrolein reacts with protein nucleophiles.
Acrolein reacts more readily with cysteine residue and are usually hard to detect in vivo
and in vitro.
A study conducted by Jian et al., (2009), where peptide models with cysteine, lysine
and histidine residue were used to investigate the reactivity of acrolein with protein
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nucleophiles. The outcome indicates that acrolein speedily reacts with cysteine residue via
Michael addition to form unstable M+56 Da abducts. Furthermore, when acrolein and
peptide model were incubated at normal body temperature, M+56 adduct was slowly
reduced following an increase of M+38 abduct formed from Schiff’s base formation, and
the emergence of M+38 was mainly influenced by peptides with cysteine residue.
Acrolein also exerts its toxicity by inactivating important enzyme, (N-arylamine
acetyltransferases) which is responsible for breaking down pollutants and xenobiotics (Bui
et al., 2013). Acrolein is involved in the development of several disease condition,
confirmed by the detection of elevated level of acrolein abduct in a patient blood sample
that is diagnosed of different diseases such as cerebral stroke, diabetic nephropathy, colon
carcinogenesis and Sjogren’s syndrome autoimmune disorder (Brooks, 2013; Igarashi et
al., 2011; Aldini et al., 2011).
Adduction of Acrolein to DNA
The

reaction

of

deoxyguanosine

(dG)

with

acrolein

to

form

1,N2

propanodeoxyguanosine (PdG) adducts in vitro was first described by the Hecht laboratory
(Stevens et al., 2007). Adduct formation can be initiated by Michael-type addition of either
N-1 or N2 of dG to C-3 of acrolein to yield two regioisomers, α- and γ-hydroxy-PdG, each
of which exist as a pair of stereoisomers. The γ-hydroxy isomer was formed as a major and
the α-hydroxy isomer as a minor product after incubation of acrolein with dG or calf
thymus DNA (Chung et al., 2001)
Acrolein produces free radicals (ROS) through the interaction with cellular
molecules (DNA) resulting in carcinogenicity and gene mutation. It exerts toxicity by
reacting readily with deoxyguanosine (dG) producing two cyclic DNA adducts, a- and c-
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hydroxy-1, N2-propano-20- deoxyguanosine leading to mutagenicity at a different level
(Tang et al., 2011). There have been cases of DNA adduct formation between 20deoxyadenosine and 20-deoxycytidine DNA bases as well as thymidine (Pawlowicz et al.,
2006; Pawlowicz et al., 2008). Acrolein abduct has been classified based on their
distinctive features in vitro and in vivo of both human and animal cells (Tang et al., 2011;
Voulgaridou et al., 2011). Acrolein DNA abduct was detected in lung tissue of both human
and rat models causing bladder cancer (Moon-shong et al., 2011), which proves that
unrepaired DNA abduct caused by acrolein is the critical cause of mutation that leads to
cancer progression (Liu et al., 2010).
It has been established that absence of natural nucleotide repair enzymes in the
mitochondria allows the buildup of acrolein abduct in mitochondrial DNA, resulting in a
transverse mutation which is supposed to be the cause of neurodegenerative disorders (Kasi
et al., 2013). Also, acrolein restrains the action of DNA methylase up to 30-50% and
impede histone acetylation comprising chromatin assembly, proposing that acrolein
exposure could be the cause of epigenetic modification in gene expression (Chen et al.,
2013).
Acrolein Induces Necrotic and Apoptotic Cell Death
Acrolein can either induce apoptosis (Nardini et al., 2002 and Tanel et al., 2005) or
have an inhibitory effect on apoptotic pathways as observed for human neutrophils
(Finkelstein et al., 2001). Acrolein induced apoptosis in human lung epithelial (HBE1)
cells at 10-25-μM and in isolated human alveolar macrophages at 25-μM exposure, as
indicated by DNA fragmentation after 24 h of exposure. Acrolein has also been reported
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to cause necrotic cell death when proB lymphoid cells were exposed to acrolein at
concentrations greater than 10 μM in the culture medium lacking serum (Kem et al., 2002).
Averill-Bates and colleagues (Tanel et al., 2005) demonstrated that acrolein can
induce apoptosis in Chinese hamster ovary (CHO) cells, either through the intrinsic
pathway which involves cytochrome c release (Tanel et al., 2007) or through the extrinsic
pathway by activation of death receptors (Tanel et al., 2007). Differences in cell types, cell
culture conditions, medium composition, and acrolein concentration may explain some of
the variable findings.
Oxidative Stress
Oxidative stress is the production of reactive oxygen species (ROS) and decrease
the ability of the body to impede their deleterious outcome through neutralization by
antioxidants. Acrolein is known to be the cause as well as the product of lipid peroxidation
and production of free radicals which is the primary cause of oxidative stress (Adams &
Klaidman, 1993; Uchida et al., 1998). Excess production of the ROS overwhelms the body
protective mechanism like natural occurring antioxidant compounds and enzymes resulting
in oxidative stress (Birben et al., 2012).
Acrolein being the initiator of oxidative stress can interrupt membrane function and
damage mitochondria and DNA aggravating apoptosis, as confirmed by in vivo and in vitro
studies (Adams & Klaidman, 1993). Acrolein is the chief cause of pathophysiological
conditions in the body such as Alzheimer's disease, gene mutations and cancers, chronic
fatigue syndrome, blood vessel disorders, atherosclerosis, heart failure, heart attack and
inflammatory diseases (Toshikazu & Yuji, 2002). Acute toxicity in the renal system is due
to acrolein produced after the metabolism of cyclophosphamide and ifosfamide used as
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anticancer drug and the toxicity is remediated by antioxidant 2-mercaptoethane sulfonate
(mesna). The method by which acrolein toxicity contribute to oxidative stress in this
situation is through the activation of intracellular reactive oxygen species and the effect on
nitric oxide, NF-kB and AP-1 (Korkmaz et al., 2007).

Figure 6:

Schematic Representation of Acrolein Mechanism of Toxicity of
Acrolein (James et al., 2001)

In this study, we investigated whether compound-20(synthetic curcumin)
ameliorate the damages caused by acrolein in rats. We determined that compound-20
suppresses acrolein-induced changes, and this inhibition results in the abolition of
oxidative stress and endoplasmic reticulum stress.

CHAPTER 3
MATERIALS AND METHODS
Reagents
Eagle’s Minimum Essential Medium (EMEM), Feta Bovine Serum (FBS),
Phosphate-Buffered saline (PBS), and Antibiotic-Antimycotic (Anti-Anti) were purchased
from Gibco by Life Technologies. Dimethyl Sulfoxide (DMSO) was purchased from
Thermo Fisher Scientific (USA).
Indoor Dust Samples & Preparation
Trace metal indoor dust and Organic Contaminants of indoor dust are the two types
that were used in the study. These dust samples were pursued from the National Institute
of Standards and Technology (NIST, Gaithersburg, MD, USA). In each 1 ml of phosphatebuffered saline, a 50 mg of each dust types was diluted, vortexed, transferred to a dark
glass vail, and finally stored -80°C refrigerator. Fresh Concentration of dust samples
concentrations were prepared in 5 ml of a complete media. Eight 25 ml tubes were used
for each dust samples and final the concentrations were as followed. (0, 10, 25, 50, 75, 100,
250, 500 µg/ml). After use, these concentrations were refrigerated in -20ºC for future use.
Cell Culture of CCD841
After receiving CCD841 cells (ATCC® CRL-1790™), the cells have been
transformed from variants of primary cultures of normal human colon epithelial cells.
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CCD841 cells were cultured in pre- prepared media Eagle’s Minimum Essential Medium
(EMEM) which was supplemented with 5% Feta Bovine Serum (FBS), 0.5% EGF, and 1%
antibiotic-antimycotic, and lastly incubated.
Cell Viability Assays (MTT & Protease Viability)
MTT

Assay

Overview:

MTT

(3-(4,

5-Dimethylthiazol-2-yl)-2,

5-

diphenyltetrazolium bromide designates tetrazolium salt which is usually used to identify
the presence of reductive metabolism in cells for proliferation, cytotoxicity, and viability
(Harris, 2019). Upon reduction, tetrazolium salts change into products that are deeply
colored and can easily be measured using colorimetric. A purple formazan product is
formed by MTT which has to be solubilized before any quantification (Lowry et al., 1951).
Protease Viability Assay Overview: (GF-AFC Assay): Protease Viability Assay
(GF-AFC Assay) is a cell-permeable fluorogenic protease substance that is used to measure
live-cell protease activity. It is worth noting that GF-AFC Assay is split by a live-cell
protease to generate a proportional fluorescent signal that is used to determine the number
of cells that are viable (Wang et al., 2017). This method has a shorter incubation time of
0.5-1 hour as compared to that of tetrazolium assays of 1-4 hours. This approach gives
room for multiplexing with other existing assays in similar sample cells such as
bioluminescent since it does not allow cells to lyse.
Cell Cytotoxicity Assay using Lactate Dehydrogenase Release
Lactate Dehydrogenase Release Overview
This is a colorimetric assay that avails a reliable and simple means of determining
the cytotoxicity of cellular. Lactate dehydrogenase is a cytosolic enzyme found in different
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types of cells that are usually released within the cell culture medium after the plasma
membrane is damaged (Bonini et al., 2002).
Cell Death by Apoptosis Assay (Caspase-Glo 3/7 Activation) Overview
It detects and quantifies cellular events that are associated with cell death that are
programmed including caspase activation, DNA fragmentation, and exposure of cell
surface to phosphatidylserine (PS) (Hammerling, 2012). Types of these assays include the
luminescent Caspase-Glo Assays which are used to identify the availability of caspases
that are either involved in extrinsic or intrinsic apoptosis pathways.
Extracellular Reactive Oxygen Species Detection Using
(ROS-Glo™ H2O2 Assay) Overview
Extracellular reactive oxygen species (ROS) are made by living cells as cellular
metabolic by-products that are normal. Cells usually produce large quantities of ROS under
conditions that are stressful (Banks and Peters, 2010). Additionally, living organisms
develop continuous response mechanisms in order to adapt to the exposure of ROS and use
it as a molecule for signaling. ROS molecules generally initiate oxidative stress as a
feedback mechanism that involves biological activities such as necrosis, autophagy, and
apoptosis. Evidence shows that ROS plays an important role that signals molecules in the
entire cell death pathway.
Inflammatory Assay Using Caspase 1-Inflammasome Activity Overview
Inflammasome-Caspase 1 assay is a simple, bioluminescent, and homogenous
technique used to selectively quantify the caspase-1 activity of caspase-1 which is a crucial
element of the inflammasomes. Inflammasomes refer to protein complexes that are induced
by different inflammatory stimuli (Sittampalam, 2004). Inbred immune cells react to

22
pathogens and any other signal of danger with the formation of inflammasome and the
change of procaspase-1 zymogen into caspase-1 that is catalytically active. Activation of
caspase 1 leads to the production and release of cytokines IL-18 and IL-1β pyroptosis
which is an immunogenic type of cell death (Sittampalam, 2004).
Software and Statistical Analysis to Obtain Experiment
Since the date obtained belong to a total of three independent experiment, standard
deviation was used in statically analyze the data by using GraphPad Prism software
generation 9, and probability value was calculated afterward to test the significance of
experiments to determine if the hypothesis of the study was supported by the ran
experiments or not.

CHAPTER 4
RESULTS AND DISCUSSION
Glutathione-S-transferase (GST) Activity Assay (Colorimetric)
This assay kit is simple and accurate to measure the activity of Glutathione-STransferase (GST)in different biological samples. This kit is based upon the GST
substrate, CDNB (1-chloro-1,2-dinitrobenzene), which has the broadest range of
isozyme detectability. Most times the interaction between glutathione and CDNB is
totally dependent on the presence of active GST.This GST-catalyzed formation of
GS-DNB produces a dinitrophenyl thioether which can be detected by
spectrophotometry at OD 340nm.
GST is a family of enzymes that plays an important role in detoxification of
xenobiotics. To determine the effect of acrolein on GST enzyme, we measured the activity
of GST enzyme activity in rat serum, using GST activity assay kit. The group of rats treated
with acrolein showed 56% (p≤0.0335) decrease in GST activity when compared with the
untreated control group. Meanwhile, the group treated with acrolein plus compound-20
showed 264.3% (p≤0.0073) increase in GST activity when compared with the acrolein
treated group (Figure 7). Sprague Dawley rats were treated with 2mg/kg/day of acrolein,
with or without 20mg/kg/day of C20 for seven (7) days. 50uL of rat’s serum was used to
measure the GST activity. The values are expressed as mean ± SEM; Using Unpaired t-test
*P≤0.05 when compared to Control, #P≤0.05 when compared with *.
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Graph showing the GST Activity of different samples.
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Figure 7:

Graph Showing the GST Activity of Different Samples

GSH + GSSH/GSH Assay (Colorimetric)
The GSH Assay is a luminescent-based assay for the detection and
quantification of glutathione(GSH) in cells or in various biological samples. A change
in GSH levels is important in the assessment of toxicological responses and is an
indicator of oxidative stress, potentially leadingto apoptosis or cell death. GSH +
GSSH/GSH assay is a method used to analyze either total glutathione or the reduced
form glutathione. This assay is based on the glutathione recycling system by DTNB
and glutathione reductase. When DTNB react with glutathione to generate 2- nitro-5thiobenzioc acid which as a yellow color. This method is used to demonstrate how
acrolein induce toxicity and how compound-20 reversed the damages caused by
acrolein. GSH was measured in rat’s serum of treated and untreated rats. The group
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treated with acrolein shows39% “P value 0.0021’’ decrease when compared with the
untreated group. Meanwhile, the grouptreated with compound-20 plus acrolein shows
78% ‘‘P value 0.0060’’ increase when compared with acrolein group. (Figure 8).
Sprague Dawley rats were treated with 2mg/kg/day of acrolein, with or without
20mg/kg/day of C20 for seven (7) days. 20uL of rat’s serum was used to measure the
GSH. The values are expressed as mean ± SEM; Using Unpaired t-test. *P≤0.05 when
compared to Control, #P≤0.05 when compared with *.

A graph showing the total glutathione of different samples.
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Figure 8:

A Graph Showing the Total Glutathione of Different Samples

Superoxide Dismutase Activity Assay (Colorimetric)
SOD activity assay is used to measure the antioxidant enzyme activity in the
rat’s serum. SOD isthe only antioxidant enzyme that scavenges the superoxide anion
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by converting this free radical to oxygen and hydrogen peroxide, thus preventing
peroxynitrite production and further damage. the assay uses a tetrazolium salt WST1 that produces water soluble formazan dye upon reduction with superoxide anion.
The rate at which WST-1 reduces relates to the inhibition of xanthine oxidase (XO)
by SOD. This assay is used to show how acrolein induced toxicity in ratsby inhibiting
the SOD activity and how compound-20 on the other hand, countered its toxicity
effect by ameliorating the damages caused by acrolein. The group treated with
acrolein shows 13% ‘P value 0.0006’ decrease in SOD activity when compared with
the untreated group. Meanwhile, the group treated with compound-20 plus acrolein
shows 32% ‘‘P value 0.0001’’increase when compared with acrolein group (Figure
9). Sprague Dawley rats were treated with 2mg/kg/day of acrolein, with or without
20mg/kg/day of C20 for seven (7) days. 20uL of rat’s serum was used to measure the
SOD activity. The values are expressed as mean ± SEM; Using Unpaired t-test.
*P≤0.05 when compared to Control, #P≤0.05 when compared with *.
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SOD Activity (inhibition rate %) of different sample groups.
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Figure 9:

SOD Activity (inhibition rate%) of Different Sample Groups

Lipid Peroxidation (MDA) Assay (Colorimetric)
Lipid peroxidation assay is useful for detecting levels of oxidative damages to the
cells of tissues which can lead to inflammatory diseases, angina, stroke, cancer,
atherosclerosis, and the ageing process. This Assay method is used to measure the
malondialdehyde (MDA) without TBARS (Thiobarbituric acid reactive substances)
heating steps. MDA color reagent reacts with MDA to generate a blue color. This assay
method is used to demonstrate how acrolein caused toxicity by increasing lipid
peroxidation and how compound-20 reversed the damages caused by acrolein.
The group treated with acrolein shows 346.1% ‘‘P value 0.0065’’ increase in lipid
peroxidation when compared with the untreated group while the group treated with
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compound-20 plus acrolein shows 158% ‘‘P value 0.0169’’ decrease when compared with
acrolein group (Figure 10). Sprague Dawley rats were treated with 2mg/kg/day of acrolein,
with or without 20mg/kg/day of C20 for seven (7) days. 50uL of rat’s serum was used to
measure the lipid peroxidation. The values are expressed as mean ± SEM; Using Unpaired
t-test. *P≤0.05 when compared to Control, #P≤0.05 when compared with *.

Graph showing lipid peroxidation of different samples.
1.5

✱✱✱

✱✱✱

1.0

Absorbance at OD700

0.5

A
cr
ol
ei
n

+

le
i
cr
o
A

C

n

l
tr
o
C
on

20

0.0

Sample groups

Figure 10: Graph Showing Lipid Peroxidation of Different Samples

CHAPTER 5
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Effect of Acrolein in Glutathione-S-transferase (GST) Activity
Biochemical biomarkers are increasingly used in ecological risk assessment of the
ecosystems to identify incidence and effects of xenobiotics. This is because of their
potential rapid early warning signal against potentially damaging effects caused by
stressor. There is increasing evidence that aldehydes, including acrolein generated
endogenously during the degradation process of biological molecules or the metabolism of
foreign chemicals may be involved in the pathogenesis of cardiovascular diseases, such as
atherosclerosis. Because glutathione (GSH) and GSH S-transferase (GST) are a major
cellular defense against the toxic effects of reactive aldehyde (Cao et al., 2016). Research
has shown GSTs are ubiquitous enzymes that catalyze the conjugation of reduced
glutathione (GSH) with reactive electrophiles. Glutathione- S-Transferase (GST) is a major
cellular defense mechanism against the toxic effects of reactive aldehydes which cause
oxidative stress and molecular damages (Cao, et al., 2016) old ones. More preferably not
more than 5 years old. Reactive constituents (such as Acrolein) of cigarette smoke are
metabolized and detoxified by glutathione-S-transferases (Conklin et al., 2009). To show
acrolein induce toxicity in rats through inhibition of the glutathione-s- transferase activity
and the amelioration effect of compound-20, GST activity was measured in rat serum using
ABCAM glutathione-s-transferase activity assay kit. The assay demonstrates how GST29
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catalyzed reaction between reduced glutathione (GSH) and GST substrate, CDNB (1chloro-2,4-dinitrobenzene) (Figure 7). The result demonstrated that the group of rats
treated with acrolein showed 56% decrease in GST activity when compared with the
untreated control group; meanwhile, the group treated with acrolein, and compound-20
showed 264% increase in GST activity when compared with the acrolein treated group.
This shows that one possible mechanism of acrolein causing toxicity in rat could be through
inhibition of detoxifying enzymes such as GST. The damages caused by acrolein are
responsible for different types of disease conditions like cancer and cardiovascular
diseases. Also, this study shows that compound-20 activating a repair mechanism to
reverse the damages caused by acrolein. Nonetheless, our findings agree with that of (Cao
et al., 2016) the inducibility of GST by the unique chemoprotective agent, 3H-1,2-dithiole3-thione (D3T) and their protective effects againstacrolein-induced toxicity in rat aortic
smooth muscle A10 cells.
Effect of Acrolein in Reduced and Total Glutathione (GSH + GSSH/GSH) Assay
Acrolein reacts rapidly and depletes cellular glutathione (GSH) when exposed
either by inhalation or ingestion and is toxic to various types of cells. Previous research has
shown that Curcumin has been proposed for the treatment of neurodegenerative diseases,
oxidative stress, asit promotes GSH formation which is an antioxidant (Raza et al., 2008).
The role of GSH in toxicology has been the subject of many investigations. Glutathione is
an antioxidant that fights off free radicals and stressors to the cells (Lan-Ying et al., 2018).
Furthermore, the development of structural analogs of curcumin is one of the most effective
approaches in fighting off oxidative stress and free radicals; these synthetic curcumin
analogs were developed in our institute and have been shown to exhibit greater
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bioavailability and anti-cancer effects than natural curcumin (Ohori, 2006). To demonstrate
that acrolein induced toxicity in rats and prove that compound-20 (synthetic curcumin)
reversed the damages caused by acrolein, levels of GSH was measured using ABCAM
GSH assay kit. GSH being the biomarker generally used to indicate its levels in toxicology
research, our results showed that groups treated with acrolein showed a 39% decrease of
GSH when compared with the control group while the group treated with compound-20
plus acrolein showed 78% increase in glutathione when compared with the acrolein group.
Our findings agree with that of Lan-Ying et al., (2018). They investigated GSH antioxidant
properties directly through scavenging free radicals and indirectly through modulating the
cytoprotective response such as upregulating the transcription of proteins involved in
replenishing the

antioxidant glutathione. They did this by using HT22 murine

hippocampal neuronal cells. These cells were treated with 25 μM acrolein for 24 h with or
without pre-treating with curcumin at the selected optimum concentration (5 μg/mL) for
30 min.Cell viability and apoptosis were measured by CCK8 assay and flow cytometric
analysis. Levels of glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde
(MDA) were detected by a GSH assay kit or commercial assay kits, respectively.
Alterations in the expression of BDNF/TrkB and key enzymes involved in amyloid
precursor protein (APP) metabolism were assessed by western blotting.
Effect of Acrolein in Superoxide Dismutase Activity
Superoxide dismutase (SOD) is that antioxidant enzyme which catalyzes the
dismutation of O2-. to H2O2 and molecular oxygen, it is an essential antioxidant enzyme
that protects against oxidative stress because of presence of free radicals (Klug et al., 2010).
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SOD is an important component of the cellular defense mechanism against oxygen toxicity.
The inactivation of Cu,Zn-SOD by acrolein is able to induce the perturbation of the
antioxidant system. In addition, the copper ions released from the Cu,Zn-SOD oxidatively
damaged by acrolein can enhance the metal-catalyzed reaction to produce ROS, which
induce oxidative damage to the other macromolecules (Jung Hoon Kang, 2013). Previous
studies by Jung Hoon Kang (2013) have shown that SOD activity can be affected by high
level of free radicals or stressors such as acrolein which has the capacity to cause oxidative
stress. To prove that acrolein causes toxicity in rats by damaging SOD, we measured the
level of SOD activity using ABCAM superoxide Dismutase activity assay kit. Our results
showed that groups treated with acrolein showed a 13%significant decrease in SOD activity
when compared with the control group and addition of C20 significantly increased SOD
activity by 32%. This implies that Compound-20 must have a an antioxidative effect to
increase the SOD activity. Also, our findings agree with that of Jung Hoon Kang (2013)
when found out that inactivation of many enzymes during oxidative modification is due to
the alteration of amino acid residues. To test this possibility, he analyzed amino acids in
acrolein-treated SOD. The results show that serine, histidine, arginine, threonine, and
lysine residues are particularly sensitive to modification by acrolein, and SOD activity was
reduced dramatically.
Effects of Acrolein in Lipid Peroxidation
Research has shown that Lipid peroxidation has received renewed attention from
the viewpoints of nutrition and medicine. Lipid peroxidation happens because of reaction
between cellular lipidsand free radicals which leads to oxidative stress (Gerschman et al.,
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2013). Lipid peroxidation is implicated in the underlying mechanisms of several disorders
and diseases such as cardiovascular diseases, cancer, neurodegenerative diseases, and even
aging, with increasing evidence showing the involvement of in vivo oxidation in these
conditions (Lan-Ying et al., 2018). To show acrolein damage might be through induced
lipid peroxidation because of its generation of free radicals, we used ABCAM Lipid
peroxidation assay kit that measures malondialdehyde (MDA) a widely used biomarker to
detect level of lipid peroxidation (Figure 9). The result showed that acrolein significantly
induced lipid peroxidation. In the acrolein group, there was a 346% increase of lipid in the
rat’s serum when compared with the untreated control group. On the other hand, the group
treated with C20 plus acrolein showed 157.5% significant decrease of lipid peroxidation in
the rat serum when compared with the acrolein group. This indicated that compound-20
acted as an antioxidative agent to remove free radicals and reduce lipid peroxidation. Our
results agree with the findings of Lan-Ying et al., 2018.They studied the effect of curcumin
on acrolein-induced neurotoxicity in HT22 cells. They found out that acrolein-induced
HT22 cells showed an increased level of MDA (Lipid peroxidation) and obviously, it is
improved by curcumin when treated with curcumin.
Conclusion
In summary, these results show a rapid increase in GST activity, SOD activity, GSH
replenishment, and reduction of lipid peroxidation in acrolein treated rats upon addition of
compound 20 and suggest that compound-20 might be a great supplement to be taken on
daily bases against oxidative stress and damages caused by acrolein-induced inflammatory
response or other environmental pollutants that share similar type of effect on these
compounds.
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